Cocktail therapy including bleomycin and verapamil as a promising treatment choice for keloid scarsopen access
- Authors
- Park, Jun Ho; Chang, Hak
- Issue Date
- Jul-2020
- Publisher
- 대한미용성형외과학회
- Keywords
- Keloid scar; Bleomycin; Verapamil; Cocktail therapy
- Citation
- Archives of Aesthetic Plastic Surgery, v.26, no.3, pp 99 - 104
- Pages
- 6
- Journal Title
- Archives of Aesthetic Plastic Surgery
- Volume
- 26
- Number
- 3
- Start Page
- 99
- End Page
- 104
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/19484
- DOI
- 10.14730/aaps.2020.02159
- ISSN
- 2234-0831
2288-9337
- Abstract
- Background The treatment of keloids is both challenging and controversial. Until now, there is no definitive treatment modality for keloids. To determine the efficacy and safety of an intralesional cocktail therapy, including bleomycin compared to corticosteroid injection method on the treatment of keloid scars. Methods A retrospective chart review was performed for 35 patients diagnosed with keloids. The cocktail therapy regimen consisted of bleomycin, 1% lidocaine, verapamil, and triamcinolone, which was further diluted with 1 mL of normal saline. In group B, 1 mL of triamcinolone acetonide was injected into the lesion. Results for a total of 35 patients included in this study were evaluated according to their therapeutic responses and complications six months after the last session. Results Analyzing the outcomes of the patients treated with a cocktail regimen (group A), it was found that 87% showed favorable therapeutic responses (scar thickness <50%). In group B, 58% of patients showed favorable therapeutic responses. No major complications were observed in both groups. Conclusions High therapeutic response rates without major complications were identified in this study, suggesting that cocktail therapy with bleomycin can be considered a safe and effective treatment modality for keloid scars.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.